Showing results (41-50 of 66) with videos related to
Sort By:
Pageof 7
Oncotarget|July 10, 2015
Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myelomaYi Li, Yuhuan Zheng, Tianshu Li, et al.Nature Communications|November 20, 2020
Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9Lintao Liu, Enguang Bi, Xingzhe Ma, et al.Journal for Immunotherapy of Cancer|January 4, 2025
Depletion of myeloid-derived suppressor cells sensitizes murine multiple myeloma to PD-1 checkpoint inhibitorsWei Xiong, Liuling Xiao, Rui Duan, et al.Biomarker Research|September 27, 2025
NPC1 as a novel therapeutic target for induction of pyroptosis in cancersChuanchao Zhang, Qiang Wang, Pan Su, et al.Nature Communications|June 25, 2014
p38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppressionYong Lu, Mingjun Zhang, Siqing Wang, et al.Blood|May 23, 2007
Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myelomaJianfei Qian, Jin Xie, Sungyoul Hong, et al.The Journal of Clinical Investigation|October 16, 2012
Th9 cells promote antitumor immune responses in vivoYong Lu, Sungyoul Hong, Haiyan Li, et al.Journal for Immunotherapy of Cancer|January 24, 2024
Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancersJianfei Qian, Qiang Wang, Liuling Xiao, et al.Journal of Hematology & Oncology|May 7, 2022
A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitorsPan Su, Liuling Xiao, Lingqun Ye, et al.Oncotarget|April 21, 2015
Anti-β₂-microglobulin monoclonal antibodies overcome bortezomib resistance in multiple myeloma by inhibiting autophagyMingjun Zhang, Jin He, Zhiqiang Liu, et al.Pageof 7